Article

The future promise of advanced therapies in ophthalmology

Six years after the first approved gene therapy in ophthalmology, the field is seeing a flurry of activity in innovative cell and gene therapy (CGT) studies addressing high unmet needs. Here’s what could be in store for the future.

Louis Cicchini
Director, Scientific Affairs, Cell & Gene Therapy at Cencora

Fill out the form below to read more

Pardot Form

Related resources

The portraits of two subject matter experts are contained in bubbles. Between them is a speech bubble icon.

Story | Expanding access globally

Table Talk: Beyond the breakthrough

Learn more

Article

The JCA unleashed: Key takeaways and outlook from early reports

Learn more

Webinar

Building HTA‑ready evidence with AI‑enabled early modeling

Learn more

Connect with our cell and gene experts

Schedule some time with our cell and gene experts today. We look forward to hearing from you.